1. Home
  2. DAIO vs PMN Comparison

DAIO vs PMN Comparison

Compare DAIO & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$2.86

Market Cap

29.1M

Sector

Industrials

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$17.84

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
PMN
Founded
1969
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Electrical Products
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.1M
34.6M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
DAIO
PMN
Price
$2.86
$17.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.22
$42.67
AVG Volume (30 Days)
21.1K
188.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
110.28
EPS
N/A
N/A
Revenue
$21,769,000.00
N/A
Revenue This Year
$7.40
N/A
Revenue Next Year
$2.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$0.29
52 Week High
$3.49
$19.85

Technical Indicators

Market Signals
Indicator
DAIO
PMN
Relative Strength Index (RSI) 40.07 74.83
Support Level $2.56 $0.43
Resistance Level $2.90 $19.85
Average True Range (ATR) 0.15 1.30
MACD -0.02 0.10
Stochastic Oscillator 18.04 96.96

Price Performance

Historical Comparison
DAIO
PMN

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: